Abiopharma

🔍 Eisenberg Or (Executive)

Company: NeuroSense Therapeutics Ltd. (NRSN)

Report Date: 2026-03-26

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Ordinary Shares (Direct)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,254,050.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.